KIORA PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Revenue
KIORA PHARMACEUTICALS, INC. (KPRX) reported Increase (Decrease) in Deferred Revenue of $1.25 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2025-11-07
- KIORA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2024-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was $669.21K, a 85.57% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$92.00K.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2017 was $8.09M.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2015 was $1.91M.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2014 was $0.00.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.25M 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | $1.25M 10-Q · filed 2025-08-08 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | ||||
| 2018-06-30 | $669.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $577.21K 10-Q · filed 2018-08-03 | $2.64M derived: sum of 3 quarters · filed 2018-08-03 | $4.03M derived: sum of 4 quarters · filed 2018-08-03 | |
| 2018-03-31 | -$92.00K 10-Q · filed 2018-05-11 | $1.97M derived: sum of 2 quarters · filed 2018-05-11 | $3.36M derived: sum of 3 quarters · filed 2018-05-11 | $8.00M derived: sum of 4 quarters · filed 2018-08-03 | |
| 2017-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $3.45M derived: sum of 2 quarters · filed 2018-03-02 | $8.09M derived: sum of 3 quarters · filed 2018-08-03 | $8.09M 10-K · filed 2018-03-02 | |
| 2017-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $6.03M derived: sum of 2 quarters · filed 2018-08-03 | $6.03M 10-Q · filed 2017-11-14 | $5.98M derived: sum of 4 quarters · filed 2018-08-03 | |
| 2017-06-30 | $4.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $4.64M 10-Q · filed 2018-08-03 | $4.59M derived: sum of 3 quarters · filed 2018-08-03 | $3.98M derived: sum of 4 quarters · filed 2018-08-03 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-11 | -$48.32K derived: sum of 2 quarters · filed 2018-05-11 | -$655.82K derived: sum of 3 quarters · filed 2018-05-11 | -$798.46K derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | -$48.32K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | -$655.82K derived: sum of 2 quarters · filed 2018-03-02 | -$798.46K derived: sum of 3 quarters · filed 2018-03-02 | $0.00 10-K · filed 2018-03-02 | |
| 2016-09-30 | -$607.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$750.13K derived: sum of 2 quarters · filed 2017-11-14 | $48.32K 10-Q · filed 2017-11-14 | $1.96M derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | -$142.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $655.82K 10-Q · filed 2017-08-04 | $2.56M derived: sum of 3 quarters · filed 2017-08-04 | $2.56M derived: sum of 4 quarters · filed 2017-08-04 | |
| 2016-03-31 | $798.46K 10-Q · filed 2017-05-05 | $2.71M derived: sum of 2 quarters · filed 2017-05-05 | $2.71M derived: sum of 3 quarters · filed 2017-05-05 | $2.71M derived: sum of 4 quarters · filed 2017-05-05 | |
| 2015-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $1.91M derived: sum of 2 quarters · filed 2017-02-23 | $1.91M derived: sum of 3 quarters · filed 2017-02-23 | $1.91M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | $0.00 10-Q · filed 2016-11-01 | $1.00M 10-Q · filed 2015-11-12 | $0.00 derived: sum of 4 quarters · filed 2016-11-01 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $0.00 10-Q · filed 2016-08-10 | $0.00 derived: sum of 3 quarters · filed 2016-08-10 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-13 | $0.00 derived: sum of 2 quarters · filed 2016-05-13 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 | |||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |